This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (2)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Social Bookmarking   What's this?

Arch Ophthalmol. 2002;120:387-388.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

IN A CLASSIC Peanuts cartoon, Lucy declares triumphantly that "with nothing more than a simple eye patch, we have brought amblyopia to its knees." Elegant in its simplicity, occlusion of the sound eye has remained an effective and standard treatment of amblyopia since it was initially described in the middle of the 18th century.¹ Despite this, amblyopia still is one of the leading causes of monocular blindness in people between the ages of 20 and 70 years.¹ More recently, atropine sulfate to blur the sound eye, a treatment referred to as "pharmacologic penalization," has been advocated as an alternative to traditional occlusion therapy.

Despite some reports of success and the theoretical benefits with penalization therapy, 97% of surveyed pediatric ophthalmologists indicated that they use traditional occlusion as their initial treatment choice for children with amblyopia.² In light of this statistic, it may be wise for us to remember the musings . . . [Full Text of this Article]

Corresponding author and reprints: Burton J. Kushner, MD, Department of Ophthalmology and Visual Sciences, University of Wisconsin, 2870 University Ave, Suite 206, Madison, WI 53705 (e-mail: bkushner@facstaff.wisc.edu).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

A Randomized Trial of Atropine vs Patching for Treatment of Moderate Amblyopia in Children
The Pediatric Eye Disease Investigator Group
Arch Ophthalmol. 2002;120(3):268-278.
ABSTRACT | FULL TEXT  

The Clinical Profile of Moderate Amblyopia in Children Younger Than 7 Years
The Pediatric Eye Disease Investigator Group
Arch Ophthalmol. 2002;120(3):281-287.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pediatric Eye Disease Investigator Group Amblyopia Treatment Review
Rees et al.
Amer. Orthoptic Jrnl. 2007;57:99-103.
ABSTRACT